Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-24-021000

Chief Operating Officer bought 32,508 shares at an average $0.79 ($25,574)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cittadine Andrew Chief Operating Officer 2024-06-18 Purchase +12,000 $0.86 $10,320 165,624 D: show line 1 in the form
Cittadine Andrew Chief Operating Officer 2024-06-20 Purchase +20,508 $0.74 $15,254 186,132 D: show line 2 in the form
Open-market purchases · 32,508 sh · avg $0.79 · $25,574
Loading xslF345X05/rdgdoc.xml…